January 2, 2026 – TheNewswire - Vancouver, B.C. – Herbal Dispatch Inc. (CSE: HERB, OTC: LUFFF, FRA: HA9) (“Herbal Dispatch” or the “Company”) announces that it has granted an aggregate of 2,760,000 restricted share units (“RSUs”) to certain officers, directors, employees, and consultants of the Company pursuant to the Company’s amended and restated stock option plan and restricted share unit plan dated effective October 16, 2020 (the “Plan”). The RSUs vest in three equal installments on July 1, 2026, Janua ...

MONTREAL, Québec, Jan. 02, 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“Cannara”, “the Company”, “us” or “we”) (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis products at affordable prices with two mega facilities based in Québec spanning over 1,650,000 sq. ft., is pleased to announce preliminary success in the Québec provincial vape cartridge category launch. Estimated retail sales data indicates multiple leadership positions across the nascent categor ...

Sector Overview - Vice stocks experienced mixed performance in 2025, with Philip Morris International rising nearly 34% and AB InBev increasing about 29%, while Molson Coors fell 18% [1] - Despite challenges, vice stocks are considered "recession-proof" and are expected to remain resilient in the market [2] Cannabis Industry - President Trump signed an executive order reclassifying marijuana from Schedule 1 to Schedule 3, marking a significant regulatory change for the cannabis sector [4] - Companies in the cannabis industry are facing difficulties accessing financial services and capital, leading to investor wariness [4] Nicotine Market - The shift towards smokeless products is evident, with 41% of Philip Morris's revenue derived from smoke-free products like Zyn [4] - Philip Morris successfully defended against a class-action lawsuit regarding pricing practices for Zyn, the only FDA-approved nicotine pouch [4] Alcohol Sector - Sales of beer, wine, and spirits are declining, with Molson Coors reporting a loss of $2.9 billion in the fall quarter and anticipating a 4% sales drop this year [4] - AB InBev reported its slowest profit growth since 2021, while the industry faces challenges from the "sober-curious" trend [4]

Core Viewpoint - The cannabis industry has seen significant stock growth recently, driven by optimism regarding regulatory changes in the U.S. cannabis market, particularly following President Trump's executive order reclassifying cannabis to a Schedule 3 drug [2][4]. Group 1: Market Performance - Tilray Brands' shares have increased by 125% over the past six months, while Curaleaf Holdings' shares have risen by 212% during the same period [1]. - Current market capitalization for Tilray Brands is $1.0 billion, with a current price of $9.03 and a gross margin of 20.17% [6]. - Curaleaf Holdings has a market capitalization of $1.9 billion, with a current price of $2.52 and a gross margin of 35.95% [8]. Group 2: Regulatory Impact - The reclassification of cannabis will not legalize it at the federal level but will facilitate research into medical uses, improve banking access for cannabis companies, and allow for normal business expense deductions [4]. - This regulatory change could lead to a lower effective tax rate for multistate operators (MSOs) like Curaleaf Holdings, potentially improving their financial performance [4][5]. Group 3: Industry Challenges - Despite the positive regulatory changes, the inability to engage in interstate commerce remains a significant barrier, forcing MSOs to manage their supply chains independently in each state, which increases operational costs [7]. - The loosening restrictions may attract more competition, leading to potential oversupply issues that could depress prices and hinder profit generation for companies [9]. - The presence of illegal channels for cannabis sales in the U.S. continues to pose a challenge, and it is uncertain if recent regulatory changes will significantly impact this issue [9]. Group 4: Future Outlook - The current rally in cannabis stocks may extend into the next year but is expected to lose momentum thereafter, suggesting a cautious outlook for sustained growth in the industry over the next few years [10].

TAMPA, Fla., Dec. 31, 2025 (GLOBE NEWSWIRE) -- FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) (“FLUENT” or the “Company”), today announced that it has completed the sale of its Pennsylvania operations to HIVE Holdings, Inc., effective December 31, 2025 for US$12.5 million in cash. The proceeds from the transaction were used to reduce FLUENT’s outstanding debt, which is expected to meaningfully enhance its balance sheet, allowing the Company to further concentrate capital and operational resources on its core grow ...

Key Takeaways CRON agreed to buy CanAdelaar, gaining a leading position in the Netherlands' regulated adult-use market.Village Farms exited fresh produce, fueling 758% year-over-year growth in Q3 medical cannabis export sales.TLRY is expanding European medical cannabis while using beverages to offset volatility in core operations.2025 shaped up to be a breakthrough year for the cannabis industry. After years of muted growth and battered stock prices, the sector finally began showing signs of life as long-aw ...

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company†or "Organigram†), Canada's #1 cannabis company by market share1, today announced the expansion of its innovation investment in Phylos Bioscience Inc. ("Phylos†), securing Organigram's position as a leader in seed-based cannabis genetics. Through an amended loan and product agreement, Organigram gains priority access to Phylos' autoflower genetics pipeline, including preferential economic terms and long-ter. ...

Market Analysis by covering: Canopy Growth Corp, Tilray Inc. Read 's Market Analysis on Investing.com ...

NEW YORK, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of SNDL Inc. (“SNDL” or the “Company”) (NASDAQ: SNDL).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether SNDL and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On December 15, 2025, SNDL a ...

VANCOUVER, BC / ACCESS Newswire / December 30, 2025 / 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTCID:TGIFF) provides the following update regarding its unsecured convertible debentures issued in 2024 (the "2024 Debentures").Debenture Conversion StatusAs of December 22, 2025, the conversion deadline set out in the debenture agreement, an aggregate of $1,035,000 of debentures were converted into units of the Company. Following these conversions, $1,563,000 of debentures remain o ...